Study Evaluating Rapamune in Transplant Recipients in the Nordic Countries

A Rapamune Follow-up Registry in Transplant Recipients in the Nordic Countries, Wrap-up

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00195195

Enrollment

Registered

2005-09-19

Start date

2005-01-31

Completion date

2008-06-30

Last updated

2012-01-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Transplantation

Keywords

Transplantation

Brief summary

The purpose of this study is to gather information about the long-term effects and safety of treatment with Rapamune in transplant patients.

Interventions

DRUGSirolimus

Transplantation patients treated with sirolimus who consent to participate in the study (register)

Study design

Observational model

CASE_ONLY

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Healthy volunteers

Inclusion criteria

* Transplantation patients treated with sirolimus (Rapamune).

Exclusion criteria

* Patients must be able to give informed consent.

Countries

Sweden

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026